Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib ,2023
Comparison of Neoadjuvant Chemotherapy and Bladder-Preserving Chemoradiation in Patients with Non-Metastatic, Muscle-Invasive Bladder Cancer: A Single-Center Experience ,2020
Relationship between the Size and Location of the Mass and Hilar and Mediastinal Lymph Node Metastasis in Early and Locally Advanced Non-small Cell Lung Cancer ,2020
Efficacy of regorafenib in the second-and third-line settingfor patients with advanced hepatocellular carcinoma: A reallife data of multicenter study from Turkey ,2020
Skeletal muscle loss during anti-epidermal growth factor receptor therapy is an independent prognostic factor on non-small cell lung cancer patients survival. ,2021
Bildiriler
PROGNOSTIC AND PREDICTIVE MARKERS OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH METASTATIC COLORECTAL CANCER (TOG STUDY) - EROL CİHAN, HIZAL MUTLU, BİLGETEKİN İREM, AKBAŞ SİNEM, GARBİOĞLU DUYGU BAYIR, HAMDARD JAMSHID, ARSLAN ÇAĞATAY, SEVİNÇ ALPER, KÜÇÜKARDA AHMET, GÜRGENYATAĞI DİLEK, ÇAKIR EMRE, DEMİRKIRAN AYKUT, ARAZ MURAT, ÖN SERCAN, DOĞAN İZZET, ERDOĞAN ATİKE PINAR, KOCA SİNAN, KUBİLAY PINAR, EREN ORHAN ÖNDER, ÖZYÜKSELER DENİZ TATAROĞLU, YILDIRIM MAHMUT EMRE, ÇILBIR EBRU, ÇELİK EMİR, BAHÇECİ AYKUT, TAŞKAYNATAN HALİL, OYMAN ABDÜLKERİM, DENİZ GÜLHAN İPEK, MENEKŞE SERKAN, KUT ENGİN, GÜLMEZ AHMET, SAKİN ABDULLAH, NAYIR ERDİNÇ, ACAR RAMAZAN, KAHRAMAN SEDA, ŞEN ERDEM, İNAL ALİ, TURHAL NAZIM SERDAR, KAYA ALİ OSMAN, PAYDAŞ SEMRA, TAŞTEKİN DİDEM, HACIBEKİROĞLU İLHAN, ÇİÇİN İRFAN, BİLİCİ AHMET, ŞENER DEDE DİDEM, AKINCI MUHAMMED BÜLENT, MANDEL NİL MOLİNAS, ÖKSÜZOĞLU BERNA, UNCU DOĞAN, YALÇIN BÜLENT, ARTAÇ MEHMET, ŞENDUR MEHMET ALİ NAHİT
A case of Treatment and Patient Endometriım Canser Nursing Care - ÇİÇİN İRFAN,TEKBAŞ SERAP,DEDEOĞLU DEMİR BURCU
EFFICACY AND SAFETY OF FOLFIRI/AFLIBERCEPT IN PREVIOUSLY TREATED METASTATIC COLORECTAL CANCER PATIENTS (TOG STUDY) - EROL CİHAN, HIZAL MUTLU, BİLGETEKİN İREM, akbaş sinem, ŞENER DEDE DİDEM, AKINCI MUHAMMED BÜLENT, YALÇIN BÜLENT, ÇİÇİN İRFAN, ŞENDUR MEHMET ALİ NAHİT, ARTAÇ MEHMET, bayır garipoğlu duygu, bayır garipoğlu duygu, ARSLAN ÇAĞATAY, KÜÇÜKARDA AHMET, ARAZ MURAT
MO31-2 Telisotuzumab vedotin monotherapy in patients with previously treated c-Met+ advanced non-small cell lung cancer - Horinouchi Hidehito, Goldman J.W., Moiseenko F., ÇİÇİN İRFAN, Filippova E., Bar J., Tomasini P., Ocampo C., Sullivan D., Maag D., Motwani M., Jin J., Camidge D.R.
LBA7 A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829) - Cho B.C., Ahn MJ, Kang JH, Soo R, Yang JCH, ÇİÇİN İRFAN, Kim DW, Wu Y-L., Lu S., Lee K., Pang Y-K., imina A. Z, Fong C.H., Poddubskaya E., Ki Y., An T, Lee H., Byun H., Zaric B.
Kitaplar
HR pozitif HER2 negatif meme kanserinde tedaviler ve güncel yakşaımlar – Türkiye Klinikleri
Clinical Research at MENA, Challenges and Solutions – PETER LANG
Geriatrik Onkoloji – Türkiye Klinikleri
Prostat Kanseri Yönetimi – EMA Tıp Kitabevi Yayıncılık Tic. Ltd. Şti.
Son Dönem Kanser Hastasında Nütrisyonel Tedavi – Türkiye Klinikleri
